Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
Beyond Air, Inc. has entered into an agreement to sell its 58% stake in NeuroNOS Israel Ltd., a biopharmaceutical company focused on neurological disorders, to UNIVO Pharmaceutical Industries Ltd. In exchange, Beyond Air will receive 19.99% ownership in UNIVO, warrants, and milestone payments up to $32.5 million tied to NeuroNOS's development and c…